According to Roche's latest financial reports the company's current earnings (TTM) are $16.74 B. In 2023 the company made an earning of $16.74 B a decrease over its 2022 earnings that were of $17.67 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $16.74 B | -5.25% |
2022 | $17.67 B | -7.18% |
2021 | $19.04 B | -6.56% |
2020 | $20.37 B | 18.81% |
2019 | $17.15 B | 19.24% |
2018 | $14.38 B | 14.35% |
2017 | $12.57 B | -1.49% |
2016 | $12.76 B | 5.24% |
2015 | $12.13 B | -4.17% |
2014 | $12.66 B | -23.47% |
2013 | $16.54 B | 24.16% |
2012 | $13.32 B | 5.16% |
2011 | $12.66 B | 5.61% |
2010 | $11.99 B | 21.26% |
2009 | $9.89 B | -27.14% |
2008 | $13.57 B | 0.44% |
2007 | $13.51 B | 30.67% |
2006 | $10.34 B | 48.58% |
2005 | $6.96 B | 20.49% |
2004 | $5.77 B | 46.41% |
2003 | $3.94 B | -212.78% |
2002 | -$3.5 B | -167.07% |
2001 | $5.21 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $21.36 B | 27.57% | ๐บ๐ธ USA |
Novartis NVS | $9.82 B | -41.32% | ๐จ๐ญ Switzerland |
Pfizer PFE | $0.89 B | -94.69% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $6.53 B | -60.96% | ๐บ๐ธ USA |
Amgen AMGN | $4.34 B | -74.05% | ๐บ๐ธ USA |
Sanofi SNY | $7.26 B | -56.64% | ๐ซ๐ท France |
Becton Dickinson BDX | $1.64 B | -90.18% | ๐บ๐ธ USA |
Merck MRK | $5.11 B | -69.45% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $6.88 B | -58.88% | ๐ฌ๐ง UK |